Health Care · Biotechnology
MannKind Corporation: Risk & public record
MannKind Corporation: 13 research papers in five years, $20k of EU lobbying in 2026.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
MANNKIND CORP
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
MannKind Corporation: 13 research papers in five years, $20k of EU lobbying in 2026.
Research outputpapers its people wrote, per OpenAlex
13papers in five years
5.4kcitations
Inhalation and Respiratory Drug Delivery
Medicine
45 papers
Diabetes Management and Research
Medicine
41 papers
Diabetes Treatment and Management
Medicine
34 papers
Immunotherapy and Immune Responses
Immunology and Microbiology
31 papers
T-cell and B-cell Immunology
Immunology and Microbiology
27 papers
Influence
US lobbying
2026 · JEFFREY J. KIMBELL & ASSOCIATES, INC. $20,000 · disclosurespreview.house.gov ↗
$20k
Patents
Published US applications
37
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
